Abstract: The present invention provides a composition for topical administration to the skin for treating and/or preventing a dermatological condition involving an abnormal decrease in the cell-to-cell adhesion between epithelial cells comprising a zinc salt which is at least partially soluble in water and an acid, wherein the composition has a pH less than or equal to 6. The dermatological condition is generally selected from eczema, dermatitis, atopic eczema, atopic dermatitis, non-atopic eczema, non-atopic dermatitis, seborrheic eczema, irritant contact dermatitis, allergic contact dermatitis, pruritus and sensitive skin. A preferred composition comprises zinc lactate, lactic acid and has a pH of about 4.0 to 5.0.
Type:
Application
Filed:
August 31, 2007
Publication date:
March 18, 2010
Applicant:
YORK PHARMA PLC
Inventors:
Simon J. Ward, Alice MacGowan, Michael J. Cork, Adrian Davis
Abstract: A composition comprising a pharmaceutically acceptable group (2, 4, 12, 13 or 14) metal compound for the treatment of a dermatological condition involving an abnormal decrease in the cell-to-cell adhesion between epithelial cells in the epidermal barrier.
Type:
Application
Filed:
August 21, 2006
Publication date:
May 14, 2009
Applicant:
YORK PHARMA PLC
Inventors:
Simon Ward, Alice MacGowan, Michael J. Cork, Jonathan Hadgraft, Majella Lane, Adrian Davis, Richard Guy